Vanda Pharmaceuticals CEO Mihael Polymeropoulos' 2007 pay jumps 209% to $11M
Vanda Pharmaceuticals reports 2007 executive compensation
By ExecPay News
Published: April 2, 2008
Vanda Pharmaceuticals reported fiscal year 2007 executive compensation information on April 2, 2008.
In 2007, five executives at Vanda Pharmaceuticals received on average a compensation package of $4.3M, a 150% increase compared to previous year.
Average pay of disclosed executives at Vanda Pharmaceuticals
Mihael H. Polymeropoulos, Chief Executive Officer, received $11M in total, which increased by 209% compared to 2006. 95% of Polymeropoulos' compensation, or $11M, was in option awards. Polymeropoulos also received $135K in non-equity incentive plan, $421K in salary, as well as $6.8K in other compensation.
William D. Chip Clark, Secretary, received a compensation package of $5.7M, which increased by 207% compared to previous year. 93% of the compensation package, or $5.3M, was in option awards.
Steven A. Shallcross, Chief Financial Officer, earned $2.4M in 2007, a 153% increase compared to previous year.
Paolo Baroldi, Chief Medical Officer, received $1.8M in 2007, which increases by 332% compared to 2006.
Albert W. Gianchetti, Senior Vice President and Chief Commercial Officer, earned $327K in 2007.
Related executives
Mihael Polymeropoulos
Vanda Pharmaceuticals
Chief Executive Officer
William Clark
Vanda Pharmaceuticals
Secretary
Steven Shallcross
Vanda Pharmaceuticals
Chief Financial Officer
Paolo Baroldi
Vanda Pharmaceuticals
Chief Medical Officer
Albert Gianchetti
Vanda Pharmaceuticals
Senior Vice President and Chief Commercial Officer
You may also like
Source: SEC filing on April 2, 2008.